RS

Ranjeet Singh Sisodiya

Active Director Director DIN 09399948
DIN 09399948 First appointment Nov 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2021
Shareholding value •••• Premium profile

About Ranjeet Singh Sisodiya

Data last updated:

Ranjeet Singh Sisodiya is a Director at Aureum Healthcare Private Limited (since 2021). The company operates in Pharma. Aureum Healthcare Private Limited reported revenue of ₹26 Lakh (FY 2025).

DIN 09399948
Primary Designation Director
Industry Pharma
First Appointment 15 Nov 2021
Oldest Company Age 4 yrs
Largest company Aureum Healthcare Private Limited · ₹26 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aureum Healthcare Private Limited U51909GJ2021PTC127307
Director15 Nov 20212021₹26 Lakh (FY 2025)Active

Board colleagues of Ranjeet Singh Sisodiya

NameDINCompanyDesignation
Anil Sharma10680768Aureum Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aureum Healthcare Private Limited
Premium access

Shareholding and investment profile for Ranjeet Singh Sisodiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ranjeet Singh Sisodiya

Ranjeet Singh Sisodiya currently holds 1 directorship: Aureum Healthcare Private Limited (Director, since 15 Nov 2021, revenue ₹26 Lakh (FY 2025)).

Ranjeet Singh Sisodiya was first appointed on 15 Nov 2021 as Director at Aureum Healthcare Private Limited.

The current boards of Ranjeet Singh Sisodiya's companies include Anil Sharma (Aureum Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available